BackConduit Pharmaceuticals Overview

Conduit Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for CDT.

Quarterly Cost of Revenue

$438.29M
↑ 15.64% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$1.74B
↑ 49.32% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin